Home Legal Mounjaro Lawsuit

Mounjaro Lawsuit

Mounjaro lawsuits claim the Type 2 diabetes drug can cause severe gastrointestinal problems such as gastroparesis, ileus or intestinal blockage. In February 2024, Mounjaro lawsuits were consolidated with other similar drugs in a federal multidistrict litigation.

This is an active lawsuit

See If You Qualify for a Weight Loss and Diabetes Drug Lawsuit

You may be entitled to compensation if you were injured after taking a medication like Ozempic, Saxenda or Wegovy. For a free case review, complete the form or call 866-898-3173.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews
Last Modified: May 14, 2024
Fact Checked

Editors carefully fact-check all Drugwatch.com content for accuracy and quality.

Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us


"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Mounjaro Lawsuit Status

On Feb. 2, 2024 Mounjaro lawsuits were among 55 lawsuits targeting its drug class combined in a federal multidistrict litigation in the Eastern District of Pennsylvania.

As of May 2024, lawsuits against Mounjaro are in their initial stages, and there have been no settlements or jury trials scheduled yet. The law firm Morgan & Morgan filed the first lawsuit on behalf of Jaclyn Bjorkland. The firm is now investigating several thousand claims, according to attorney Jonathan Sedgh.

The Bjorkland lawsuit and others claim Mounjaro (tirzepatide) and Ozempic (semaglutide), another Type 2 diabetes drug, caused serious personal injury with symptoms ranging from severe vomiting to gastrointestinal burning. Several other Ozempic lawsuits make similar claims.

Latest Updates in Mounjaro Lawsuits

  • February 2024:
    Mounjaro lawsuits were included among 55 lawsuits claiming GLP-1 RAS class drugs — which also include Ozempic and Wegovy — consolidated into a multidistrict litigation in Pennsylvania. Plaintiffs' lawyers said as many as 10,000 such lawsuits may eventually be filed.
  • December 2023:
    Novo Nordisk attempted to get Jaclyn Bjorklund's Ozempic lawsuit dismissed, but a judge cleared it to proceed. Bjorklund also named Eli Lilly and Mounjaro in her lawsuit.
  • September 2023:
    Eli Lilly filed lawsuits against compounding pharmacies, medspas and wellness centers over the fraudulent distribution of counterfeit products labeled as Mounjaro.
  • August 2023:
    The law firm Morgan & Morgan filed a claim in federal district court on behalf of its client, Jaclyn Bjorklund. The named defendants are Novo Nordisk and Eli Lilly and Company.
  • May 2022:
    The U.S. Food and Drug Administration approved Eli Lilly’s Mounjaro to help control blood sugar levels in patients with Type 2 diabetes. The approval notes the risk of gastrointestinal side effects.
Show More

Although Eli Lilly and Company’s Mounjaro is FDA-approved to treat Type 2 diabetes, many doctors prescribe it off-label as a weight loss medication. Clinical studies have shown it to be more effective than semaglutide for weight loss and blood sugar control. However, it can cause serious health complications that require hospitalization for treatment.

So far, there are no Mounjaro class-action lawsuits, and the existing lawsuits are product liability cases.

Why Are Mounjaro Lawsuits Being Filed?

Mounjaro can cause serious gastrointestinal side effects, including gastroparesis, or stomach paralysis. Severe gastroparesis can cause prolonged vomiting that lasts for at least four weeks and it’s a key qualifier for joining the ongoing Mounjaro lawsuits. Lawyers are also investigating cases for ileus and intestinal blockages or obstructions. Patients claim Eli Lilly failed to provide adequate warnings about the risks of severe side effects associated with using Mounjaro.

This relatively new Type 2 diabetes medication targets how the body digests food by activating the GLP-1 and GIP receptors. For some patients, it slows digestion and absorption to the point that the stomach no longer functions properly. Certain foods, such as those high in fat, can increase the likelihood of negative side effects with this class of medications.

“Plaintiff was caused to suffer from severe gastrointestinal events, which resulted in, for example, severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room.”

Although there is no current FDA approval for the purpose, many doctors prescribe Mounjaro for weight loss. Some wellness centers and compounding pharmacies are also producing their own versions of the medication, potentially increasing the risk of side effects and patient harm.

What Is Gastroparesis?

Gastroparesis is a disorder caused when food moves too slowly or stops moving from the stomach to the small intestine. It is a serious medical condition. It can contribute to malnutrition, dehydration and acute kidney disorders.

Symptoms of gastroparesis include bloating, early satiety, nausea, upper abdominal pain and vomiting that can last for weeks or months. If food remains in the stomach too long it may form into masses called bezoars. These can contribute to additional gastrointestinal problems such as intestinal blockages and may have to be surgically removed.

Disordered stomach emptying is relatively common in patients with diabetes, but medications such as Mounjaro that affect digestion and stomach emptying can aggravate the condition. Additionally, GLP-1 receptors may trigger gastroparesis in some patients with no history of the condition.

Clinical trials of semaglutide and tirzepatide found an increased risk of this severe side effect. The FDA noted this in its approvals of the medications and manufacturers include it in patient warning information. In September 2023, the FDA added a warning for intestinal blockages to the Ozempic label.

See if You Qualify for a Lawsuit Our Partners

Our Trusted Legal Partners

Drugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.

simmons hanly conroy law firm logo weitz and luxenberg logo sokolove law firm logo levin papantonio rafferty law firm logo nigh goldenberg raso and vaughn law firm logo morgan & morgan logo the ferraro law firm logo meirowitz & wasserberg law firm logo

Qualifying to File a Mounjaro Lawsuit

In order to qualify for a Mounjaro lawsuit, people must have taken Mounjaro and suffered from prolonged vomiting, gastroparesis, ileus and intestinal obstruction or blockage. It is important to remember that not everyone who took Mounjaro and experienced side effects qualifies to file a lawsuit.

The best way to establish eligibility for joining ongoing litigation is to speak with an experienced attorney. During a consultation, they will review your case and determine if you qualify to file a claim seeking compensation for medical expenses and lost wages.

How to File a Mounjaro Lawsuit

If you decide to seek compensation for injuries related to taking Mounjaro, consult with a knowledgeable attorney. A legal professional can determine how to proceed and guide you through the process of filing a lawsuit.

Steps for Filing a Mounjaro Lawsuit
  • Consult an experienced product liability attorney.
  • Work with the law firm to gather any necessary documentation.
  • Have your attorney file a claim on your behalf.

It’s important to decide whether you want to join a Mounjaro class-action lawsuit or file an individual injury claim. Class actions typically claim financial damages related to the purchase of the drug or faulty product. So far, there are no established class actions, and attorneys are only accepting gastroparesis claims.

Choosing a Mounjaro Lawyer

Filing lawsuits against Mounjaro is a major undertaking that requires experience and subject matter knowledge. The firm you choose will represent you throughout the entire legal process. Therefore, finding the right attorney is critical to a successful claim.

Qualities of Top Mounjaro Lawyers
  • Clear Communicator: Look for an attorney who has a clear style of communication and explains things in a way you understand.
  • Demonstrated Record of Success: Product liability attorneys should be able to provide examples of successful litigation that are similar to your case.
  • Free Consultations: Top injury attorneys offer free consultations and case reviews to give you a clear picture of where you stand.
  • Personal Compatibility: You should be comfortable speaking with your attorney and sharing personal details related to your health and the effects of taking Mounjaro.
  • Transparent Payment Structure: Ask about how your attorney will structure any attorneys fees. In product liability injury cases, it’s typical that attorneys only take their fee if they recover a settlement or jury verdict on your behalf.

Make sure you interview at least three law firms and pick the one that works best for you. Experience, a history of success in similar cases and good communication are three of the most important things to look for in an attorney.

Please seek the advice of a medical professional before making health care decisions.